KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Deferred Taxes (2019 - 2024)

Historic Deferred Taxes for GoodRx Holdings (GDRX) over the last 6 years, with Q4 2024 value amounting to -$11.3 million.

  • GoodRx Holdings' Deferred Taxes fell 4884.46% to -$11.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$11.9 million, marking a year-over-year increase of 8182.79%. This contributed to the annual value of -$11.9 million for FY2024, which is 8182.79% up from last year.
  • GoodRx Holdings' Deferred Taxes amounted to -$11.3 million in Q4 2024, which was down 4884.46% from -$642000.0 recorded in Q3 2024.
  • GoodRx Holdings' Deferred Taxes' 5-year high stood at $46.1 million during Q4 2021, with a 5-year trough of -$63.0 million in Q2 2023.
  • Moreover, its 5-year median value for Deferred Taxes was -$291500.0 (2021), whereas its average is -$4.8 million.
  • Examining YoY changes over the last 5 years, GoodRx Holdings' Deferred Taxes showed a top increase of 245948.72% in 2023 and a maximum decrease of 10874655.17% in 2023.
  • GoodRx Holdings' Deferred Taxes (Quarter) stood at -$13.2 million in 2020, then skyrocketed by 448.95% to $46.1 million in 2021, then crashed by 100.77% to -$356000.0 in 2022, then tumbled by 2027.25% to -$7.6 million in 2023, then crashed by 48.84% to -$11.3 million in 2024.
  • Its Deferred Taxes was -$11.3 million in Q4 2024, compared to -$642000.0 in Q3 2024 and -$7.6 million in Q4 2023.